StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.11−0.04 (-3.48%)

Close on Nov 18, 2026Market cap $80.25MP/E –Yield –

InflaRx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was €29.33K, down 82.3% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025€29.33K-82.3%
FY2024Dec 31, 2024€165.79K+162.8%
FY2023Dec 31, 2023€63.09K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2025Jun 30, 2025€39.43K–
Q2 FY2024Jun 30, 2024€6.36K–

More InflaRx figures

See a number that looks wrong?